<DOC>
	<DOCNO>NCT00378404</DOCNO>
	<brief_summary>The purpose study assess maximum tolerate dose low-dose radiation combination Docetaxel recurrent metastatic non-small cell lung cancer second-line therapy .</brief_summary>
	<brief_title>Phase I Trial Docetaxel Low-Dose Fractionated Radiation Treatment Metastatic Recurrent NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Patients must 18 year age great . Histologically cytologically proven nonsmall cell lung cancer either metastatic recurrent fail least one prior platinumbased chemotherapeutic regimen . Patients recur previous surgery and/or radiation may participate trial . Patients may prior neoadjuvant adjuvant therapy . Patients know brain metastasis eligible clinical trial disease treat clinically stable document stable improve pretreatment CT MRI scan brain evaluate CNS disease within 28 day prior registration . Measurable OR nonmeasurable disease document CT , MRI , Xray nuclear exam ( FDGPET ) . Measurable nonmeasurable disease must present outside area surgical resection . Pleural effusion , ascites laboratory parameter acceptable evidence disease . Progression least one prior platinumbased chemotherapy . Greater 3 week since surgery must recover associated toxicity time registration . ANC ≥ 1,500/µl platelet count ≥ 100,000/µl obtain within 28 day prior registration . Adequate hepatic function document serum bilirubin ≤ 1.5 time institutional upper limit normal liver enzyme ( SGOT SGPT ) ≤ 2.5 x institutional upper limit normal obtain within 28 day prior registration . Patients require lung radiation must FEV1 &gt; 1000 liter obtain within 28 day prior registration must pulmonary function test DLCO . Zubrod Performance Status 0,1 2 . No prior singleagent , weekly Docetaxel chemotherapy . Peripheral neuropathy ≥ Grade 1 . Prior malignancy except follow : adequately treat basal cell squamous cell skin cancer , situ cervical cancer , adequately treated Stage I II cancer patient currently complete remission cancer patient diseasefree 5 year . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>Non-Small Cell</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Radiation</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Recurrent</keyword>
</DOC>